Find details of the 2025 third quarter consolidated sales

Since August, our teams in France offer a new antiparasitic collar, protecting cats and dogs for up to 8 months from external parasites, addressing the global need to combat vector-borne diseases. In addition to ticks and fleas, it protects dogs against lice and reduces the risk of transmission of leishmania with indirect use on the vector. This new solution that supports continuum of care will progressively be available in other European countries, starting with Germany, Netherlands and Slovenia.

We are going to increase our vaccine production capacity with the construction of a new industrial site, Bio 5, in Carros (Alpes-Maritimes). This project, the foundation stone of which was laid on October 1st, is positioned as the Group's center of excellence for companion animal vaccines.